During a live event, Richard F. Riedel, MD, discussed key efficacy and safety outcomes from the phase 3 DeFi trial in ...

"The reduction in fertility rates, advancing age at first birth, and rises in obesity and alcohol consumption are likely driving rising rates of estrogen receptor-positive breast cancer," the ...

will continue to be main therapies for functioning neuroendocrine tumors over the next years. Pasireotide, a new panreceptor analog, might control clinical symptoms and hormone release in patients ...

Now, reporting in Nature Biotechnology, Flynn's team in the Stem Cell Program at Boston Children's Hospital and Dana-Farber/Boston Children's Cancer and Blood Disorders Center demonstrate a first ...

yet humans had more breast cancer when treated with estriol. Patient Beliefs About Bioidentical Hormones for Menopause Patients may believe that bioidentical hormones are safer because they are ...

Search for other works by this author on: ...

Hormone replacement therapy (HRT ... This is especially true if you’re under 60 and not at high risk of breast cancer or blood clots. The risks of taking HRT are usually low and depend on ...

Radiation therapy to the pelvis can cause sexual problems for many women with cancer. These problems can be temporary or last long-term after ... Radiation therapy to your pelvis can affect the ...

This study aimed to investigate elucidate the therapeutic mechanisms by which ursolic acid modulates estrogen conversion in the treatment of MASLD. Building upon prior studies that have ...

Armour Thyroid is a type of desiccated thyroid (DTE) medication used to treat hypothyroidism by replacing missing thyroid hormones, specifically T4 and T3. Some people prefer it because it provides ...